{"id":464626,"date":"2021-03-24T16:33:22","date_gmt":"2021-03-24T20:33:22","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=464626"},"modified":"2021-03-24T16:33:22","modified_gmt":"2021-03-24T20:33:22","slug":"osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/","title":{"rendered":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BRIDGEWATER, N.J., March  24, 2021  (GLOBE NEWSWIRE) &#8212; Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (\u201cOsmotica\u201d or the \u201cCompany\u201d), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 30, 2021, after the close of the U.S. financial markets.<\/p>\n<p>Brian Markison, Chief Executive Officer, James \u201cJD\u201d Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: bottom\">Date\u00a0<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: bottom\">Tuesday, March 30, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Time\u00a0<\/td>\n<td style=\"vertical-align: bottom\">4:30 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Toll free (U.S.)\u00a0\u00a0<\/td>\n<td style=\"vertical-align: bottom\">(866) 672-5029<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">International\u00a0<\/td>\n<td style=\"vertical-align: bottom\">(409) 217-8312<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Conference ID\u00a0<\/td>\n<td style=\"vertical-align: bottom\">5056728<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Webcast (live and replay)<\/td>\n<td style=\"vertical-align: bottom\">\n            <a href=\"http:\/\/www.osmotica.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n              <u>www.osmotica.com<\/u><br \/>\n            <\/a> under the \u201cInvestor &amp; News\u201d section<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Osmotica Pharmaceuticals plc<\/strong>\n      <\/p>\n<p>Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company\u2019s ophthalmic subsidiary supporting UPNEEQ. Vertical Pharmaceuticals, LLC represents the Company\u2019s diversified branded portfolio and Trigen Laboratories, LLC represents the Company\u2019s non-promoted products, including complex generic formulations.<\/p>\n<p>Osmotica has operations in the United States, Argentina, and Hungary.<\/p>\n<p>\n        <strong>Investor and Media Relations for Osmotica Pharmaceuticals plc<\/strong><br \/>\n        <br \/>Lisa M. Wilson<br \/>In-Site Communications, Inc.<br \/>T: 212-452-2793<br \/>E: lwilson@insitecony.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/5b2eb9b3-79f2-4bc6-8a93-5988f12f82d1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRIDGEWATER, N.J., March 24, 2021 (GLOBE NEWSWIRE) &#8212; Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (\u201cOsmotica\u201d or the \u201cCompany\u201d), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 30, 2021, after the close of the U.S. financial markets. Brian Markison, Chief Executive Officer, James \u201cJD\u201d Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows: Date\u00a0 Tuesday, March 30, 2021 Time\u00a0 4:30 p.m. ET Toll free (U.S.)\u00a0\u00a0 (866) 672-5029 International\u00a0 (409) 217-8312 Conference ID\u00a0 5056728 Webcast (live and replay) www.osmotica.com under the \u201cInvestor &amp; News\u201d section About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-464626","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRIDGEWATER, N.J., March 24, 2021 (GLOBE NEWSWIRE) &#8212; Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (\u201cOsmotica\u201d or the \u201cCompany\u201d), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 30, 2021, after the close of the U.S. financial markets. Brian Markison, Chief Executive Officer, James \u201cJD\u201d Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows: Date\u00a0 Tuesday, March 30, 2021 Time\u00a0 4:30 p.m. ET Toll free (U.S.)\u00a0\u00a0 (866) 672-5029 International\u00a0 (409) 217-8312 Conference ID\u00a0 5056728 Webcast (live and replay) www.osmotica.com under the \u201cInvestor &amp; News\u201d section About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused &hellip; Continue reading &quot;Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T20:33:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021\",\"datePublished\":\"2021-03-24T20:33:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/\"},\"wordCount\":211,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/\",\"name\":\"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\",\"datePublished\":\"2021-03-24T20:33:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/","og_locale":"en_US","og_type":"article","og_title":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk","og_description":"BRIDGEWATER, N.J., March 24, 2021 (GLOBE NEWSWIRE) &#8212; Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (\u201cOsmotica\u201d or the \u201cCompany\u201d), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 30, 2021, after the close of the U.S. financial markets. Brian Markison, Chief Executive Officer, James \u201cJD\u201d Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows: Date\u00a0 Tuesday, March 30, 2021 Time\u00a0 4:30 p.m. ET Toll free (U.S.)\u00a0\u00a0 (866) 672-5029 International\u00a0 (409) 217-8312 Conference ID\u00a0 5056728 Webcast (live and replay) www.osmotica.com under the \u201cInvestor &amp; News\u201d section About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused &hellip; Continue reading \"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-24T20:33:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021","datePublished":"2021-03-24T20:33:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/"},"wordCount":211,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/","name":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=","datePublished":"2021-03-24T20:33:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIwNTkwNCM0MDkwMjQyIzIwOTc4Nzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/osmotica-pharmaceuticals-plc-to-provide-fourth-quarter-and-full-year-2020-business-and-financial-update-on-march-30-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=464626"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/464626\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=464626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=464626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=464626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}